WHO added tocilizumab, a monoclonal antibody, to its list of prequalified treatments for #COVID19.
To date, six COVID-19 treatments have been prequalified by WHO, including the three presentations of the product prequalified today. More info 👉bit.ly/360TTqR
Tocilizumab given intravenously has been shown in clinical studies to prevent death in certain patients with #COVID19 and reduce patients’ time in hospital.
WHO recommends tocilizumab only for patients diagnosed with severe or critical #COVID19. It should be administered by a healthcare worker in a monitored clinical setting.
Currently, tocilizumab is expensive and in short supply globally. WHO and partners are currently discussing lower prices and improved access in low- and middle-income countries with the producer.
"Two years ago, as the 🌎 was still coming to grips with the spread of a new coronavirus, WHO did what only WHO can do – we convened hundreds of scientists from around the world to identify the most urgent priorities in R&D. Among them was the development of vaccines."-@DrTedros
"Tomorrow marks the second anniversary of that first meeting.
It’s incredible to think that within a year of that meeting, the first vaccines were approved, and just two years later, more than 10 billion doses have been administered globally."-@DrTedros
WHO’s global mRNA vaccine technology transfer hub in #SouthAfrica is building self-reliance & provides a one stop shop for low- & middle-income countries to benefit from the technology transferred & know-how to produce mRNA vaccines bit.ly/3GEI4TT
#COVID19 has demonstrated the importance of investments in science, technology & innovation.
For most of 2021, limited global vaccine supply led to huge disparities in #COVID19 vaccine access, leaving billions of people – especially in low- & middle-income countries – unprotected
The mRNA hub aim is to develop a training facility where mRNA technology is developed to the scale required for mass production of vaccines; then for that full package of technology to be transferrable to multiple recipients in low- & middle-income countries.
🆕 The latest update for the 11th Revision of the International Classification of Diseases (ICD-11) is now online! #ICD11 is a 'common language' for health professionals to share standardized health information around the world.
Learn more bit.ly/3HIYtZ1
The 11th International Classification of Diseases is now fully digital & multilingual with a new user-friendly format & smart coding to reduce the chance of error.
This update reflects input from over 90 countries & unprecedented involvement of health-care providers.
The #ICD11 update includes:
🔹New chapters on addictive disorders
🔹Updated diagnostic recommendations for mental health conditions & digital documentation of #COVID19 certificates
🔹More specific coding for the location & extent of conditions like cancers & fractures
Women & girls living with female genital mutilation face serious threats to their health & well-being.
These include:
🔴 infections
🔴 bleeding
🔴 psychological trauma
🔴 chronic health conditions that can occur throughout life
🔴 death
Happy 70th anniversary, GISRS! The Global Influenza Surveillance and Response System is celebrating 70 years as a global public health collaboration founded to protect people from the threat of #influenza
#Influenza is a serious global health problem that impacts all countries: every year, there are an estimated 1 billion cases of seasonal influenza causing 3 to 5 million severe cases incl. up to 650,000 influenza-related respiratory deaths globally. bit.ly/3sg4BkJ
The Global Influenza Surveillance and Response System continuously monitors #influenza & other respiratory viruses of public health significance, incl. SARS-CoV2. GISRS is a critical resource for #COVID19 disease surveillance, sequencing & testing.
UPDATED: WHO #COVID19 clinical CARE - Confirm, Assess, Respond, Evaluate - tool to support health care workers visualize the current WHO recommendations for the care of patients with COVID-19.